기본 정보
- CAS
89943-82-8- 표준 SMILES
Cc1ncc2c(c1O)COC2c1ccc(Cl)cc1- InChIKey
CVKNDPRBJVBDSS-UHFFFAOYSA-N- 분자식
- C14H12ClNO2
- 평균 분자량
- 261.7 g/mol
- 단동위원소 질량
- 261.0556563
개요
Cicletanine is an organochlorine compound.
이름 및 식별자
- 우선 이름
- Cicletanine
- IUPAC
- 3-(4-chlorophenyl)-6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol
- 영어명
- Cicletanine
- 분자식
- C14H12ClNO2
- 분자량
- 261.7
이름 및 동의어
CicletanineCycletanide89943-82-8CicletaninaCicletaninumWin 90,000Win-90000BN-1270CHG7QC509Wcicletanide3-(4-chlorophenyl)-6-methyl-1H,3H-furo[3,4-c]pyridin-7-ol3-(4-chlorophenyl)-6-methyl-1H,3H-furo(3,4-c)pyridin-7-ol
이름 더 보기
3-(4-Chlorophenyl)-1,3-dihydro-6-methylfuro[3,4-c]pyridin-7-olFuro[3,4-c]pyridin-7-ol, 3-(4-chlorophenyl)-1,3-dihydro-6-methyl-
RefChem:577124C03BX031,3-dihydro-6-methyl-7-hydroxy-3-(4-chlorophenyl)furo(3,4-d)pyridine(A+-)-BN-1270Furo(3,4-c)pyridin-7-ol, 3-(4-chlorophenyl)-1,3-dihydro-6-methyl-Tenstaten3-(4-chlorophenyl)-6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol(R)-(-)-CICLETANINE
데이터베이스 식별자
- CAS
89943-82-8- PubChem CID
- 54910
- DTXSID
DTXSID70868972- ChEMBL
CHEMBL191886- ChEBI
CHEBI:135078- UNII
- CHG7QC509W
- EC Number
- 630-329-0
- Nikkaji
- J55.610F
물성
구조 계산 물성
- XLogP
- 2.4
- 극성 표면적
- 42.4 Ų
- 수소 결합 공여자 수
- 1
- 수소 결합 수용자 수
- 3
- 회전 가능 결합 수
- 1
- 무거운 원자 수
- 18
- 형식 전하
- 0
- 복잡도
- 294
실험 및 물리화학적 성질
LogP2.34
물리화학적 성질
- 끓는 점
- 446.3 · 446.3±45.0 °C(Predicted)
- 밀도
- 1.351 · 1.351±0.06 g/cm3(Predicted)
- 산도 계수 (pKa)
- 5.37 · 5.37±0.40(Predicted)
안전 및 규제
GHS 분류
GHS Classification
Danger
H318 (100%): Causes serious eye damage [Danger Serious eye damage/eye irritation]
P264+P265, P280, P305+P354+P338, and P317 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
유해성 정보
Hazard Classes and CategoriesEye Dam. 1 (100%)
안전 데이터
- 신호 어
- Danger
- 유해·위험 문구
- 암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드 H318
화학 및 산업
약리 정보
ATC Code
C - Cardiovascular system
QC - Cardiovascular system
MeSH Pharmacological Classification
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Agents that promote the excretion of urine through their effects on kidney function.
응용 분야
용도Antihypertensive.
공급사6 곳
奥夫仑医药（四川）有限公司17336178085 · [email protected]
梯尔希（南京）药物研发有限公司18012923235 · [email protected]
成都同创源医药科技有限公司028-83379370 13880556291 · [email protected]
上海万千化工有限公司18796480002 18796480002 · [email protected]
上海智乾生物科技有限公司[email protected]
泰兴市海川生物科技有限公司19353112242 · [email protected]
관련 반응
5건
화합물 노트
불러오는 중…